Hoeft, K.* ; Koch, L.* ; Ziegler, S.* ; Zhang, L.* ; Luetke, S.* ; Tanzer, M.C.* ; Mohanta, D.* ; Schumacher, D.* ; Schreibing, F.* ; Long, Q.* ; Kim, H.* ; Klinkhammer, B.M.* ; Schikarski, C.* ; Maryam, S.* ; Baens, M.* ; Hermann, J.* ; Krieg, S.* ; Peisker, F.* ; De Laporte, L.* ; Schaefer, G.J.L.* ; Menzel, S.* ; Jankowski, J.* ; Humphreys, B.D.* ; Wahida, A. ; Schneider, R.K.* ; Versele, M.* ; Boor, P.* ; Mann, M.* ; Sengle, G.* ; Hayat, S.* ; Kramann, R.*
     
 
    
        
ADAMTS12 promotes fibrosis by restructuring extracellular matrix to enable activation of injury-responsive fibroblasts.
    
    
        
    
    
        
        J. Clin. Invest. 134:e170246 (2024)
    
    
    
		
		
			
				Fibrosis represents the uncontrolled replacement of parenchymal tissue with extracellular matrix (ECM) produced by myofibroblasts. While genetic fate-tracing and single-cell RNA-Seq technologies have helped elucidate fibroblast heterogeneity and ontogeny beyond fibroblast to myofibroblast differentiation, newly identified fibroblast populations remain ill defined, with respect to both the molecular cues driving their differentiation and their subsequent role in fibrosis. Using an unbiased approach, we identified the metalloprotease ADAMTS12 as a fibroblast-specific gene that is strongly upregulated during active fibrogenesis in humans and mice. Functional in vivo KO studies in mice confirmed that Adamts12 was critical during fibrogenesis in both heart and kidney. Mechanistically, using a combination of spatial transcriptomics and expression of catalytically active or inactive ADAMTS12, we demonstrated that the active protease of ADAMTS12 shaped ECM composition and cleaved hemicentin 1 (HMCN1) to enable the activation and migration of a distinct injury-responsive fibroblast subset defined by aberrant high JAK/STAT signaling.
			
			
				
			
		 
		
			
				
					
					Impact Factor
					Scopus SNIP
					Web of Science
Times Cited
					Scopus
Cited By
					
					Altmetric
					
				 
				
			 
		 
		
     
    
        Publikationstyp
        Artikel: Journalartikel
    
 
    
        Dokumenttyp
        Wissenschaftlicher Artikel
    
 
    
        Typ der Hochschulschrift
        
    
 
    
        Herausgeber
        
    
    
        Schlagwörter
        Cardiology ; Fibrosis ; Nephrology; Pathway Activation; Cells; Contributes; Growth; Image
    
 
    
        Keywords plus
        
    
 
    
    
        Sprache
        englisch
    
 
    
        Veröffentlichungsjahr
        2024
    
 
    
        Prepublished im Jahr 
        0
    
 
    
        HGF-Berichtsjahr
        2024
    
 
    
    
        ISSN (print) / ISBN
        0021-9738
    
 
    
        e-ISSN
        1558-8238
    
 
    
        ISBN
        
    
 
    
        Bandtitel
        
    
 
    
        Konferenztitel
        
    
 
	
        Konferzenzdatum
        
    
     
	
        Konferenzort
        
    
 
	
        Konferenzband
        
    
 
     
		
    
        Quellenangaben
        
	    Band: 134,  
	    Heft: 18,  
	    Seiten: ,  
	    Artikelnummer: e170246 
	    Supplement: ,  
	
    
 
  
        
            Reihe
            
        
 
        
            Verlag
            American Society of Clinical Investigation
        
 
        
            Verlagsort
            2015 Manchester Rd, Ann Arbor, Mi 48104 Usa
        
 
	
        
            Tag d. mündl. Prüfung
            0000-00-00
        
 
        
            Betreuer
            
        
 
        
            Gutachter
            
        
 
        
            Prüfer
            
        
 
        
            Topic
            
        
 
	
        
            Hochschule
            
        
 
        
            Hochschulort
            
        
 
        
            Fakultät
            
        
 
    
        
            Veröffentlichungsdatum
            0000-00-00
        
 
         
        
            Anmeldedatum
            0000-00-00
        
 
        
            Anmelder/Inhaber
            
        
 
        
            weitere Inhaber
            
        
 
        
            Anmeldeland
            
        
 
        
            Priorität
            
        
 
    
        Begutachtungsstatus
        Peer reviewed
    
 
     
    
        POF Topic(s)
        30203 - Molecular Targets and Therapies
    
 
    
        Forschungsfeld(er)
        Genetics and Epidemiology
    
 
    
        PSP-Element(e)
        G-506900-001
    
 
    
        Förderungen
        Max Planck Society for the Advancement of Science
German Society for Cardiology Otto-Hess MD
German Research Foundation (DFG)
Europe-an Research Council
Else Kroener Fresenius Foundation (EKFS)
BMBF
BMBF consortia CureFib
DFG
European Research Council
Federal Ministry of Education and Research (BMBF)
German Society of Internal Medicine Peter Scriba
    
 
    
        Copyright
        
    
 	
    
    
    
    
    
        Erfassungsdatum
        2024-10-28